Thermo Fisher Scientific (TMO) Work In Process (2009 - 2026)

Thermo Fisher Scientific has disclosed Work In Process across 11 years of filings, most recently posting $942.0 million for Q1 2026.

• Quarterly Work In Process rose 7.78% year-over-year to $942.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $942.0 million (up 7.78% YoY) and the FY2025 annual result came in at $889.0 million, up 17.75% from the prior year.
• Work In Process grew to $942.0 million in Q1 2026, from $889.0 million in the prior quarter.
• Over five years, Work In Process peaked at $990.0 million in Q3 2025 and troughed at $705.0 million in Q4 2023.
• A 4-year average of $871.7 million and a median of $889.0 million in 2025 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2024 — Work In Process gained 7.09% — and 2025, when it gained 17.75%.
• Tracing TMO's Work In Process over 4 years: stood at $705.0 million in 2023, then increased by 7.09% to $755.0 million in 2024, then advanced by 17.75% to $889.0 million in 2025, then gained by 5.96% to $942.0 million in 2026.
• Business Quant data shows TMO's Work In Process at $942.0 million in Q1 2026, $889.0 million in Q4 2025, and $990.0 million in Q3 2025.